| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.0065 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |